The annual J.P. Morgan Healthcare Conference reunited biopharma investors, executives and stakeholders in San Francisco for the first time since 2020 and while attendees embraced the face-to-face interactions and the chance to be reunited with old colleagues and friends, wariness of COVID-19, heavy downpours and investor sentiment all seemed to weigh on optimism over the course of the meeting.
Regeneron Pharmaceuticals, Inc. CEO Len Schleifer summed up some of that sentiment when he took the stage in a...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?